FTSE All-Share
4.991,61
PKT
+5,27
PKT
+0,11
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.12.15 | BT Group buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.12.15 | Unilever Reduce | Nomura | |
| 09.12.15 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 09.12.15 | Rio Tinto buy | UBS AG | |
| 09.12.15 | Unilever Equal-Weight | Morgan Stanley | |
| 09.12.15 | Unilever Equal-Weight | Morgan Stanley | |
| 09.12.15 | BP Underperform | Merrill Lynch & Co., Inc. | |
| 08.12.15 | Rio Tinto buy | Citigroup Corp. | |
| 08.12.15 | Prudential Neutral | JP Morgan Chase & Co. | |
| 08.12.15 | Vodafone Group kaufen | Morgan Stanley | |
| 08.12.15 | Sky buy | UBS AG | |
| 08.12.15 | Unilever Neutral | UBS AG | |
| 08.12.15 | Unilever Neutral | Credit Suisse Group | |
| 08.12.15 | BT Group Underperform | BNP PARIBAS | |
| 07.12.15 | Unilever Equal-Weight | Morgan Stanley | |
| 07.12.15 | Unilever Equal-Weight | Morgan Stanley | |
| 07.12.15 | AstraZeneca buy | Jefferies & Company Inc. | |
| 07.12.15 | GSK Hold | Jefferies & Company Inc. | |
| 04.12.15 | Barclays kaufen | Independent Research GmbH | |
| 04.12.15 | Sky buy | UBS AG | |
| 04.12.15 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 04.12.15 | Unilever Neutral | Citigroup Corp. | |
| 03.12.15 | AstraZeneca overweight | Morgan Stanley | |
| 03.12.15 | AstraZeneca overweight | Morgan Stanley | |
| 03.12.15 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.12.15 | Sky buy | Nomura | |
| 03.12.15 | Unilever buy | HSBC | |
| 02.12.15 | Barclays buy | Deutsche Bank AG | |
| 02.12.15 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 02.12.15 | Prudential overweight | Morgan Stanley | |
| 02.12.15 | Barclays overweight | JP Morgan Chase & Co. | |
| 02.12.15 | Standard Chartered overweight | JP Morgan Chase & Co. | |
| 02.12.15 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 02.12.15 | Barclays buy | Goldman Sachs Group Inc. | |
| 02.12.15 | GSK Equal-Weight | Morgan Stanley | |
| 02.12.15 | AstraZeneca overweight | Morgan Stanley | |
| 01.12.15 | Diageo buy | UBS AG | |
| 01.12.15 | BT Group Neutral | Nomura | |
| 01.12.15 | Vodafone Group buy | Nomura | |
| 01.12.15 | Shell (ex Royal Dutch Shell) overweight | Barclays Capital |